Table 3.
Allergic rhinitis | Allergic asthma | p-value | |
Symptom score | |||
Nose and eyes | 2.4 (1.1, 3.9) | 3.8 (1.9, 4.9) | 0.37 |
Respiratory | 1.3 (0, 4.2) | 1.3 (0.4, 2.0) | 0.83 |
Total | 3.8 (2.4, 6.7) | 4.2 (3.0, 6.9) | 0.67 |
Medication score | |||
Oral anti-histamine | 1 (1, 1) | 1 (0, 1.1) | 0.67 |
Topical * | 1.75 (0.25, 2) | 0.9 (0, 2.6) | 0.83 |
Beta-2-agonists | 0 (0, 0) | 0.6 (0.2, 1.9) | 0.006* |
Total | 3 (1.2, 3.5) | 2.7 (0.5, 5.6) | 0.79 |
Lung function | |||
Morning PEFR (L/min) | 575 (550, 620) | 475 (433, 551) | 0.020 |
Evening PEFR (L/min) | 610 (555, 630) | 478 (449, 551) | 0.005 |
ΔFEV1 ** | -0.07 (-0.37, 0.2) | -0.21 (-0.43, -0.16)) | 0.26 |
* Topical medication: anti-histamines and/or cromones
** Change in FEV1 in % compared with before-season spirometry